Sleep Cycle AB (publ) Stock Price

Sleep Cycle faces slower user growth and a weaker dollar, but it tries to keep revenue rising by raising prices and pushing into new health features like sleep-apnea screening. The upside comes from new ways to use its app and data, while ongoing spending and tougher competition could squeeze profits in the near term.Read more

Sleep Cycle AB — Investment Narrative, Update Q1 2025 Executive Summary Sleep Cycle AB (Nasdaq Stockholm: SLEEP) is the category-leading sleep-tracking app with ~904 000 paying subscribers and a decade-long proprietary data set exceeding three billion recorded nights. The asset-light subscription model generates robust profitability (average EBIT margin ≈ 26 % over 2022-2024) while free cash flow and a net-cash balance (≈ 157 m) support an ordinary plus special dividend.Read more

Big tech is building free sleep tracking into phones and wearables, and tougher health-data rules could make it harder for Sleep Cycle to stand out and stay profitable. Yet the company is pushing into partnerships and medical-grade features that could open new ways to grow if it executes well.Read more

Sleep Cycle could ride a wave of smartphone-led health habits by turning its sleep app into a trusted engine for device makers and healthcare partners, not just individual users. But falling downloads and the risk that big phone and wearable platforms bake similar features directly into their products could challenge its ability to keep growing.Read more

Sleep Cycle is trying to move beyond a simple sleep-tracking app by selling its technology to partners and bringing an AI-based health screening product to market, which could open new ways to grow. But falling subscriber numbers, dependence on mobile app stores, and tougher competition could keep pressure on growth unless these newer bets pay off.Read more